Author name: andrewshd

Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System

Houston, TX (July 30, 2019) – Procyrion, Inc., a medical device company developing percutaneous circulatory support devices for the treatment of heart failure, announced today that it has secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Aortix™ System. Aortix is a circulatory support device for chronic heart failure patients […]

Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System Read More »

Procyrion Raises $30 Million Series D to Support Clinical Trials of its Aortix™ Percutaneous Blood Pump for Treating Heart Failure Patients

Houston, TX (July 9, 2019) – Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $30 million Series D funding round led by a new investor, Bluebird Ventures. Returning investors include Fannin Partners, Scientific Health Development, the State of Texas, and an undisclosed strategic investor. The company is developing its Aortix™ system,

Procyrion Raises $30 Million Series D to Support Clinical Trials of its Aortix™ Percutaneous Blood Pump for Treating Heart Failure Patients Read More »

Podimetrics Hires Former CVS Health Executive to Lead Expansion into Private Payer Markets

Care management company prepares to further growth in the private health plan market SOMERVILLE, Mass., July 9, 2019 — Podimetrics, a care management company with the leading solution to help prevent costly and deadly diabetic foot ulcers, today announced Simon Salgado has joined the team as Vice President, Enterprise Health Services. Salgado spent the last

Podimetrics Hires Former CVS Health Executive to Lead Expansion into Private Payer Markets Read More »

Liberate Medical Presents Data from its Pilot Trial of VentFree,™ a Muscle Stimulator for Mechanically Ventilated Patients, at the American Thoracic Society 2019 International Conference

Results Presented as an Oral Presentation Crestwood, KY, May 21, 2019 – Liberate Medical, a clinical-stage medical device company, developing novel electrical muscle stimulation devices that non-invasively address pulmonary conditions, today announced the results from its recently completed pilot trial of the VentFree Muscle Stimulator during an oral presentation at the American Thoracic Society International Conference (“ATS”)

Liberate Medical Presents Data from its Pilot Trial of VentFree,™ a Muscle Stimulator for Mechanically Ventilated Patients, at the American Thoracic Society 2019 International Conference Read More »

Podimetrics Raises $13.4 Million to Expand Innovative Solution for Diabetes Complications

Investment will accelerate the company’s business development among VA hospitals and commercial payers SOMERVILLE, Mass., May 9, 2019 — Podimetrics, a care management company with the leading solution to help prevent costly and deadly diabetic foot ulcers (DFUs), today announced it has closed a $13.4 million Series B funding round. Participants included Rock Health, Norwich

Podimetrics Raises $13.4 Million to Expand Innovative Solution for Diabetes Complications Read More »

Channel Medsystems® Receives U.S. FDA Approval of the Cerene® Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding

Emeryville, California, April 2, 2019. Channel Medsystems®, a company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that the U.S. Food and Drug Administration (FDA) has approved the Cerene® Cryotherapy Device as a new approach to treating heavy menstrual bleeding. The Cerene Device delivers cryotherapy to freeze the lining of the

Channel Medsystems® Receives U.S. FDA Approval of the Cerene® Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding Read More »

Liberate Medical’s VentFree™ Muscle Stimulator Receives Breakthrough Device Designation from the FDA to Reduce Mechanical Ventilation Duration

Crestwood, KY, 24th January 2019 – Liberate Medical, a clinical stage medical device company, focused on the development of novel non-invasive neuromuscular electrical stimulation devices to address pulmonary conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s VentFree muscle stimulator. The proposed indication for the

Liberate Medical’s VentFree™ Muscle Stimulator Receives Breakthrough Device Designation from the FDA to Reduce Mechanical Ventilation Duration Read More »

Procyrion Named Most Innovative Heart Pump Technology in 2018 Global Healthcare and Pharmaceutical Awards

HOUSTON, TEXAS (August 23, 2018) – Houston medical device developer Procyrion Inc. today announced they have won the Most Innovative Heart Pump Technology award in the 2018 Global Healthcare and Pharmaceutical Awards for their device, Aortix™, a catheter-deployed circulatory support device designed initially to address cardiorenal syndrome in heart failure patients. The award celebrates the

Procyrion Named Most Innovative Heart Pump Technology in 2018 Global Healthcare and Pharmaceutical Awards Read More »

Procyrion Selects Former Abbott/St. Jude Medical Group President Dr. Eric S. Fain as CEO

Houston, TX (July 23, 2018) – Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, has named Eric S. Fain, MD as President and Chief Executive Officer effective immediately. The Board of Directors tapped Dr. Fain to build upon the foundation of innovative technology established over recent

Procyrion Selects Former Abbott/St. Jude Medical Group President Dr. Eric S. Fain as CEO Read More »

Medical Device Company Procyrion, Inc. Hires Three to Support Growth; Continues to Build Team

HOUSTON, TEXAS (July 10, 2018) – Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, announced today it has hired three additional team members to support the advancement of its intra-aortic heart pump, AortixTM, for use in NYHA Class III-IV heart failure patients. Patricia DaSilva, Margo Fendrich, and Aaron

Medical Device Company Procyrion, Inc. Hires Three to Support Growth; Continues to Build Team Read More »